Skip to content
Advertisement

This photo provided by Novo Nordisk shows an injection pen of the company's drug Ozempic. On Tuesday, Dec. 5, 2017, the Food and Drug Administration approved the new, long-acting diabetes drug that reduces blood sugar levels and also helps people lose significant weight. (Novo Nordisk via AP)

This photo provided by Novo Nordisk shows an injection pen of the company's drug Ozempic. On Tuesday, Dec. 5, 2017, the Food and Drug Administration approved the new, long-acting diabetes drug that reduces blood sugar levels and also helps people lose significant weight. (Novo Nordisk via AP)

Featured Photo Galleries